EX-99.1 2 d475942dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO                 

FOR IMMEDIATE RELEASE

AMERICAN VANGUARD REPORTS FULL YEAR 2022 RESULTS

FY Net Income Increased 47% - Strong Outlook for 2023

Newport Beach, CA – March 13, 2023 – American Vanguard Corporation (NYSE: AVD) today announced financial results for the full year ended December 31, 2022.

Fiscal 2022 Full Year Financial Highlights – versus Fiscal 2021 Full Year:

 

 

Net sales were $610 million in 2022, compared to $558 million in 2021 (up 9%)

 

 

Net income was $ 27.4 million in 2022, compared to $18.6 million in 2021 (up 47%)

 

 

Earnings per diluted share of $0.92 in 2022, compared to $0.61 in 2021 (up 51%)

 

 

Adjusted EBITDA1 of $73.1 million in 2022, compared to $63.5 million in 2021 (up 15%)

Eric Wintemute, Chairman and CEO of American Vanguard, stated: “Our full-year performance in 2022 exceeded that of 2021 in virtually every financial metric with net sales up 9% and net income up 47%. With high commodity prices and a strong farm economy, our U.S. Crop business recorded increased sales of our products in corn, soybeans, cotton, potatoes, and many fruits and vegetables. Our Non-Crop business experienced flat overall sales, in spite of a 30% drop in the domestic consumer product market. Further, our international business grew by 13% year-over-year, with increased sales of soil fumigants in Mexico and Australia, a milestone $100 million net sales record in Central America and expansion of our Green Solutions business into key markets. With demand for many of the high margin products that we produce in-house, we experienced greater efficiency within our manufacturing operations. At the same time, we strengthened our balance sheet through prudent allocation of capital, generation of cash and reduction of debt.”

Mr. Wintemute continued: “Looking forward, we are well positioned in both domestic and international markets for 2023, during which we are targeting increased net sales, and consistent gross profit and operating expense performance when compared to sales. During 2023, we are forecasting higher interest rates (due to the FOMC’s regular increases in the interest rate) and consequently higher expense. At the bottom line, we expect to see a solid increase in both net income, earnings per share, and adjusted EBITDA. During 2023, we will continue to develop our key strategic growth initiatives in innovative Core products, Green Solutions and SIMPAS/Ultimus technologies.”

2023 Performance Targets

 

     Range     Growth v. 2022  

Net Sales

   $ 655M-$685M       8-12

Gross Margin %

     38-41     Similar  

OPEX as % Sales

     31-33     Similar  

Adjusted EBITDA

   $ 86M-$91M       18-25

Net Income

   $ 34M-$37M       22-34


Mr. Wintemute concluded: “During 2022 we have repurchased 1.7 million shares of the Company’s stock, representing approximately 5.5% of the outstanding shares. Furthermore, the board has authorized management to repurchase additional shares up to a total of $15 million dollars during 2023. Additionally, during 2022 we increased dividends per share by 31% reflecting our very strong financial performance. We look forward to giving you a more detailed presentation during our upcoming earnings call.”

Conference Call

Eric Wintemute, Chairman & CEO, Bob Trogele, COO, David T. Johnson, CFO, Scott Hendrix, U.S. Crop SVP and Jim Thompson, Leader of the Green Solutions Initiative, will conduct a conference call focusing on the financial results and strategic themes…at 4:30 pm ET on March 13, 2023. Interested parties may participate in the call by dialing 201-493-6744. Please call in 10 minutes before the scheduled start time and ask for the American Vanguard call. The conference call will also be webcast live via the News and Media section of the Company’s web site at www.american-vanguard.com. To listen to the live webcast, go to the web site at least 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, the conference call will be archived on the Company’s web site.

About American Vanguard

American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000® and Russell 3000® Indexes and the Standard & Poor’s Small Cap 600 Index. To learn more about American Vanguard, please reference the Company’s web site at www.american-vanguard.com.

The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.

 

Company Contact:    Investor Representative
American Vanguard Corporation    the Equity Group Inc.
William A. Kuser, Director of Investor Relations    www.theequitygroup.com
(949) 260-1200    Lena Cati
williamk@amvac-chemical.com    Lcati@equityny.com


AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

December 31, 2022 and 2021

(In thousands, except share data)

(Unaudited)

 

     2022     2021  

Assets

    

Current assets:

    

Cash and cash equivalents

   $ 20,328     $ 16,285  

Receivables:

    

Trade, net of allowance for doubtful accounts of $5,136 and $3,938,
respectively

     156,492       149,326  

Other

     9,816       9,595  
  

 

 

   

 

 

 

Total receivables, net

     166,308       158,921  
  

 

 

   

 

 

 

Inventories, net

     184,190       154,306  

Prepaid expenses

     15,850       12,488  

Income taxes receivable

     1,891       —    
  

 

 

   

 

 

 

Total current assets

     388,567       342,000  

Property, plant and equipment, net

     70,912       66,111  

Operating lease right-of-use assets

     24,250       25,386  

Intangible assets, net of amortization

     184,664       197,841  

Goodwill

     47,010       46,260  

Other assets

     10,769       16,292  

Deferred income tax assets, net

     141       270  
  

 

 

   

 

 

 

Total assets

   $ 726,313     $ 694,160  
  

 

 

   

 

 

 
Liabilities and Stockholders’ Equity             

Current liabilities:

    

Current installments of other liabilities

   $ —       $ 802  

Accounts payable

     69,000       67,140  

Customer prepayments

     110,597       63,064  

Accrued program costs

     60,743       63,245  

Accrued expenses and other payables

     20,982       20,745  

Income taxes payable

     —         3,006  

Operating lease liabilities, current

     5,279       5,059  
  

 

 

   

 

 

 

Total current liabilities

     266,601       223,061  

Long-term debt, net of deferred loan fees

     51,477       52,240  

Other liabilities, excluding current installments

     4,167       5,335  

Operating lease liabilities, long-term

     19,492       20,780  

Deferred income tax liabilities, net

     14,597       20,006  
  

 

 

   

 

 

 

Total liabilities

     356,334       321,422  
  

 

 

   

 

 

 

Commitments and contingent liabilities (Notes 5 and 11)

    

Stockholders’ equity:

    

Preferred stock, $0.10 par value per share; authorized 400,000 shares; none issued

     —         —    

Common stock, $0.10 par value per share; authorized 40,000,000 shares; issued 34,446,194 shares in 2022 and 34,248,218 shares in 2021

     3,444       3,426  

Additional paid-in capital

     105,634       101,450  

Accumulated other comprehensive loss

     (12,182     (13,784

Retained earnings

     328,745       304,385  
  

 

 

   

 

 

 
     425,641       395,477  

Less treasury stock at cost, 5,029,892 shares in 2022 and 3,361,040 in 2021

     (55,662     (22,739
  

 

 

   

 

 

 

Total stockholders’ equity

     369,979       372,738  
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 726,313     $ 694,160  
  

 

 

   

 

 

 


AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

Years ended December 31, 2022, 2021 and 2020

(In thousands, except per share data)

(Unaudited)

 

     2022     2021     2020  

Net sales

   $ 609,615     $ 557,676     $ 458,704  

Cost of sales

     (368,263     (343,629     (286,114
  

 

 

   

 

 

   

 

 

 

Gross profit

     241,352       214,047       172,590  

Operating expenses

     (200,701     (183,272     (154,339

Bargain purchase gain on business acquisition

     —         171       4,657  
  

 

 

   

 

 

   

 

 

 

Operating income

     40,651       30,946       22,908  

Change in fair value of equity investments, net

     (732     (790     717  

Other income

     —         672       —    

Interest expense, net

     (3,954     (3,687     (5,178
  

 

 

   

 

 

   

 

 

 

Income before provision for income taxes and loss on equity method investment

     35,965       27,141       18,447  

Provision for income taxes

     (8,561     (8,166     (3,080
  

 

 

   

 

 

   

 

 

 

Income before loss on equity method investment

     27,404       18,975       15,367  

Loss from equity method investment

     —         (388     (125
  

 

 

   

 

 

   

 

 

 

Net income

   $ 27,404     $ 18,587     $ 15,242  
  

 

 

   

 

 

   

 

 

 

Earnings per common share—basic

   $ 0.94     $ 0.62     $ 0.52  
  

 

 

   

 

 

   

 

 

 

Earnings per common share—assuming dilution

   $ 0.92     $ 0.61     $ 0.51  
  

 

 

   

 

 

   

 

 

 

Weighted average shares outstanding—basic

     29,234       29,811       29,450  
  

 

 

   

 

 

   

 

 

 

Weighted average shares outstanding—assuming dilution

     29,872       30,410       29,993  
  

 

 

   

 

 

   

 

 

 

AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

ANALYSIS OF SALES

For the years and quarters ended December 31, 2022 and 2021

(Unaudited)

 

     For the quarters ended
December 31,
     For the years ended
December 31,
 
     2022      2021      2022      2021  

Net sales:

           

U.S. crop

   $ 68,121      $ 79,580      $ 288,624      $ 263,632  

U.S. non-crop

     23,061        18,042        76,709        78,605  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total U.S.

     91,182        97,622        365,333        342,237  

International

     68,797        61,991        244,282        215,439  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total net sales

   $ 159,979      $ 159,613      $ 609,615      $ 557,676  
  

 

 

    

 

 

    

 

 

    

 

 

 

Gross profit:

           

U.S. crop

   $ 27,910      $ 31,255      $ 132,509      $ 109,568  

U.S. non-crop

     10,431        9,396        35,257        37,443  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total U.S.

     38,341        40,651        167,766        147,011  

International

     20,655        19,062        73,586        67,036  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total gross profit

   $ 58,996      $ 59,713      $ 241,352      $ 214,047  
  

 

 

    

 

 

    

 

 

    

 

 

 


AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

Years ended December 31, 2022, 2021 and 2020

(In thousands)

(Unaudited)

 

     2022     2021     2020  

Cash flows from operating activities:

      

Net income

   $ 27,404     $ 18,587     $ 15,242  

Adjustments to reconcile net income to net cash provided by operating activities:

      

Depreciation and amortization of property, plant and equipment and intangible assets

     22,138       22,229       19,902  

Loss on disposal of property, plant and equipment

     268       194       119  

Amortization of other long-term assets

     3,573       3,943       3,947  

Amortization and accretion of deferred loan fees and discounted liabilities

     289       359       309  

Provision for bad debts

     1,171       649       1,002  

Provision for inventory obsolescence

     340       1,034       738  

Loan principal and interest forgiveness

     —         (672     —    

Fair value adjustment of contingent consideration

     610       758       250  

Decrease in environmental liability

     —         (167     (1,155

Stock-based compensation

     5,684       6,880       6,561  

(Decrease) increase in deferred income taxes

     (5,278     (2,090     969  

Changes in liabilities for uncertain tax positions or unrecognized tax benefits

     (1,441     (1,783     (2,092

Change in equity investment fair value

     732       790       (717

Loss from equity method investment

     —         388       125  

Bargain purchase gain

     —         (171     (4,657

Net foreign currency adjustment

     (29     (225     126  

Changes in assets and liabilities associated with operations, net of business combinations:

      

(Increase) decrease in net receivables

     (6,447     (24,347     15,407  

(Increase) decrease in inventories

     (29,560     8,323       6,683  

(Increase) decrease in income tax receivable, net

     (4,910     6,051       (287

(Increase) decrease in prepaid expenses and other assets

     (3,082     (4,581     140  

Increase in net operating lease liability

     68       286       18  

Increase (decrease) in accounts payable

     1,704       8,783       (8,199

Increase in deferred revenue

     47,551       19,280       36,803  

(Decrease) increase in accrued program costs

     (2,449     17,877       (2,517

Increase in other payables and accrued expenses

     90       3,986       1,607  

Payment of contingent consideration

     (1,321     —         —    
  

 

 

   

 

 

   

 

 

 

Net cash provided by operating activities

     57,105       86,361       90,324  
  

 

 

   

 

 

   

 

 

 

Cash flows from investing activities:

      

Capital expenditures

     (13,261     (9,518     (11,249

Proceeds from disposal of property, plant and equipment

     84       —         —    

Acquisitions of businesses and product lines

     —         (10,000     (19,342

Intangible assets

     (1,293     (524     (4,014

Investment

     —         —         (1,190
  

 

 

   

 

 

   

 

 

 

Net cash used in investing activities

     (14,470     (20,042     (35,795
  

 

 

   

 

 

   

 

 

 

Cash flows from financing activities:

      

Payments under line of credit agreement

     (254,000     (186,569     (168,400

Borrowings under line of credit agreement

     253,000       131,000       126,776  

Payment of contingent consideration

     (68     (1,301     (1,227

Net receipt from the issuance of common stock under ESPP

     837       743       721  

Net receipt from the exercise of stock options

     827       172       1,603  

Net payment from common stock purchased for tax withholding

     (2,067     (2,955     (2,745

Repurchase of common stock

     (34,002     (4,579     —    

Payment of cash dividends

     (2,787     (2,382     (1,168
  

 

 

   

 

 

   

 

 

 

Net cash used in financing activities

     (38,260     (65,871     (44,440
  

 

 

   

 

 

   

 

 

 

Net increase in cash and cash equivalents

     4,375       448       10,089  

Effect of exchange rate changes on cash and cash equivalents

     (332     (86     (747

Cash and cash equivalents at beginning of year

     16,285       15,923       6,581  
  

 

 

   

 

 

   

 

 

 

Cash and cash equivalents at end of year

   $ 20,328     $ 16,285     $ 15,923  
  

 

 

   

 

 

   

 

 

 


AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES

RECONCILIATION OF NET INCOME TO EBITDA

For the years and quarters ended December 31, 2022 and 2021

(Unaudited)

 

         For the years ended December 31,  
     2022      2021  

Net income

   $ 27,404      $ 18,587  

Provision for income taxes

     8,561        8,166  

Interest expense, net

     3,954        3,687  

Proxy costs

     1,785        —    

Depreciation and amortization

     25,711        26,172  

Stock compensation expense

     5,684        6,880  
  

 

 

    

 

 

 

Adjusted EBITDA1

   $ 73,099      $ 63,492  
  

 

 

    

 

 

 

 

     For the quarters ended December 31,  
     2022     2021  

Net income

   $ 3,898     $ 4,874  

Provision for income taxes

     (1,626     2,842  

Interest expense, net

     1,698       766  

Depreciation and amortization

     6,406       6,146  

Stock compensation expense

     1,288       1,571  
  

 

 

   

 

 

 

Adjusted EBITDA1

   $ 11,664     $ 16,199  
  

 

 

   

 

 

 

 

1 

Adjusted EBITDA is not a financial measure calculated and presented in accordance with U.S. generally accepted accounting principles (GAAP) and should not be considered as an alternative to net income , operating income or any other financial measures so calculated and presented, nor as an alternative to cash flow from operating activities as a measure of liquidity. The items excluded from adjusted EBITDA are detailed in the reconciliation attached to this news release. Other companies (including the Company’s competitors) may define adjusted EBITDA differently.